BG63537B1 - Креатинови пирувати и метод за тяхното получаване - Google Patents

Креатинови пирувати и метод за тяхното получаване Download PDF

Info

Publication number
BG63537B1
BG63537B1 BG102932A BG10293298A BG63537B1 BG 63537 B1 BG63537 B1 BG 63537B1 BG 102932 A BG102932 A BG 102932A BG 10293298 A BG10293298 A BG 10293298A BG 63537 B1 BG63537 B1 BG 63537B1
Authority
BG
Bulgaria
Prior art keywords
creatine
pyruvates
pyruvic acid
pyruvate
creatine pyruvates
Prior art date
Application number
BG102932A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG102932A (en
Inventor
Ivo Pischel
Stefan Weiss
Original Assignee
Skw Trostberg Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19653225A external-priority patent/DE19653225A1/de
Application filed by Skw Trostberg Aktiengesellschaft filed Critical Skw Trostberg Aktiengesellschaft
Publication of BG102932A publication Critical patent/BG102932A/xx
Publication of BG63537B1 publication Critical patent/BG63537B1/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/185Saturated compounds having only one carboxyl group and containing keto groups
    • C07C59/19Pyruvic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Extrusion Moulding Of Plastics Or The Like (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
BG102932A 1996-12-20 1998-11-18 Креатинови пирувати и метод за тяхното получаване BG63537B1 (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19653225A DE19653225A1 (de) 1996-12-20 1996-12-20 Kreatin-pyruvate und Verfahren zu deren Herstellung
US08/893,423 US6166249A (en) 1996-12-20 1997-07-11 Creatine pyruvates
PCT/EP1997/007121 WO1998028263A1 (de) 1996-12-20 1997-12-18 Kreatin-pyruvate und verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
BG102932A BG102932A (en) 1999-09-30
BG63537B1 true BG63537B1 (bg) 2002-04-30

Family

ID=26032506

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102932A BG63537B1 (bg) 1996-12-20 1998-11-18 Креатинови пирувати и метод за тяхното получаване

Country Status (23)

Country Link
US (1) US6172111B1 (ja)
EP (1) EP0894083B1 (ja)
JP (1) JP3090960B2 (ja)
CN (1) CN1076343C (ja)
AT (1) ATE186295T1 (ja)
AU (1) AU727524B2 (ja)
BG (1) BG63537B1 (ja)
BR (1) BR9711954A (ja)
CA (1) CA2255665C (ja)
CZ (1) CZ293282B6 (ja)
DE (1) DE59700666D1 (ja)
DK (1) DK0894083T3 (ja)
ES (1) ES2139465T3 (ja)
GR (1) GR3031754T3 (ja)
HK (1) HK1020718A1 (ja)
IL (1) IL127148A (ja)
NO (1) NO311354B1 (ja)
NZ (1) NZ332830A (ja)
PL (1) PL330279A1 (ja)
RU (1) RU2179970C2 (ja)
SK (1) SK283195B6 (ja)
TR (1) TR199900470T2 (ja)
WO (1) WO1998028263A1 (ja)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1051914A1 (de) * 1999-05-08 2000-11-15 DSM Fine Chemicals Austria GmbH Verwendung von Kreatin als Futterzusatz
US6242491B1 (en) * 1999-06-25 2001-06-05 Rima Kaddurah-Daouk Use of creatine or creatine compounds for skin preservation
DE19929995B4 (de) 1999-06-30 2004-06-03 Skw Trostberg Ag Verwendung von Kreatin und/oder Kreatin-Derivaten zur Behandlung von Befindlichkeitsstörungen bei Frauen
AU6153200A (en) * 1999-06-30 2001-01-22 Skw Trostberg Aktiengesellschaft Use of creatine and/or creatine derivatives for treating feelings of ill-health in women
DE10003835A1 (de) * 2000-01-28 2001-08-16 Sueddeutsche Kalkstickstoff Formulierungen bei Dehydratationszuständen
EP1688139A1 (en) * 2000-09-14 2006-08-09 Board of Regents of the University of Nebraska Creatine ester pronutrient compounds and formulations
US20030212136A1 (en) 2001-09-14 2003-11-13 Vennerstrom Jonathan L. Creatine ester pronutrient compounds and formulations
DE10064312C2 (de) * 2000-12-22 2003-05-22 Degussa Cholinpyruvat-Hydrat, Verfahren zu dessen Herstellung, Cholinpyruvat-Hydrat enthaltende Formulierung sowie deren Verwendung
US6838562B2 (en) * 2003-04-01 2005-01-04 Sal Abraham Process for preparing a creatine heterocyclic acid salt and method of use
DE10355716A1 (de) 2003-11-26 2005-06-23 Beiersdorf Ag Kosmetische Zubereitungen mit einem Gehalt Kreatin und/oder Kreatinderivaten und/oder Kreatinin und/oderKreatininderivaten und organischen Verdickern
DE502005002355D1 (de) 2004-06-09 2008-02-07 Evonik Degussa Gmbh Guanidinoessigsäure als futtermittelzusatz
DE102006031441B4 (de) * 2006-07-05 2011-12-29 Hans Matt Orales Creatin-Supplement, sowie Verfahren zur Herstellung desselben
DE102007004781A1 (de) 2007-01-31 2008-08-07 Alzchem Trostberg Gmbh Verwendung von Guanidinoessigsäure(-Salzen) zur Herstellung eines gesundheitsfördernden Mittels
DE102007030495A1 (de) 2007-06-30 2009-01-15 Alzchem Trostberg Gmbh Verwendung einer eine Kreatin-Komponente enthaltende Zusammensetzung zur Verbesserung der Gedächtnisleistung, der Merkfähigkeit, des Langzeitgedächtnisses und zur Vorbeugung geistiger Ermüdungszustände
DE102007053369A1 (de) 2007-11-09 2009-07-02 Alzchem Trostberg Gmbh Verwendung einer eine Kreatin-Komponente enthaltende Zusammensetzung zur Verbesserung der männlichen Fruchtbarkeit
DE102007062288A1 (de) 2007-12-21 2009-06-25 Alzchem Trostberg Gmbh Kreatin-Zubereitung und Verfahren zu deren Herstellung
US20110123654A1 (en) * 2008-06-06 2011-05-26 Ralf Jaeger Synergistic enhancement of cellular ergogenic nutrient uptake, like creatine or carnitine, with tarragon
US8466198B2 (en) * 2008-09-02 2013-06-18 Bruce Kneller Compositions comprising creatine salts and methods of use thereof
WO2011090676A1 (en) 2009-12-29 2011-07-28 Hill's Pet Nutrition, Inc. Compositions including pyruvate for companion animals and methods of use thereof
AU2014280235B2 (en) 2013-06-12 2019-10-03 Anabio Technologies Limited A process for producing microcapsules comprising an active component encapsulated, protected and stabilised within a protein shell
CN111935990A (zh) 2018-03-27 2020-11-13 赢创运营有限公司 胍乙酸和/或肌酸在水产养殖中的用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1967400A (en) * 1930-03-27 1934-07-24 Schering Kahlbaum Ag Production of guanidino fatty acids
FR4508M (ja) * 1965-05-06 1966-10-17
US4548937A (en) * 1981-04-01 1985-10-22 Montefiore Hospital Method for preventing body fat deposition in mammals
ATE22655T1 (de) * 1982-11-10 1986-10-15 Laevosan Gmbh & Co Kg Infusionsloesungen zur herztherapie.
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
GB9215746D0 (en) * 1992-07-24 1992-09-09 Hultman Eric A method of increasing creatine supply depot
JP3213666B2 (ja) * 1994-02-28 2001-10-02 治彦 末岡 クレアチン飲料の製造方法
US5627172A (en) * 1994-03-04 1997-05-06 Natural Supplement Association, Incorporated Method for reduction of serum blood lipids or lipoprotein fraction
US5536751A (en) * 1994-05-09 1996-07-16 The United States Of America As Represented By The Secretary Of The Army Pharmaceutical alpha-keto carboxylic acid compositions method of making and use thereof
IT1271687B (it) * 1994-08-04 1997-06-04 Flamma Spa Sali organici idrosolubili della creatina
US5886040A (en) * 1997-06-17 1999-03-23 Amt Labs, Inc. Creatine pyruvate salt with enhanced palatability

Also Published As

Publication number Publication date
HK1020718A1 (en) 2000-05-19
CA2255665A1 (en) 1998-07-02
NO992603D0 (no) 1999-05-31
DE59700666D1 (de) 1999-12-09
CA2255665C (en) 2002-05-14
CZ293282B6 (cs) 2004-03-17
CN1224416A (zh) 1999-07-28
EP0894083B1 (de) 1999-11-03
NO992603L (no) 1999-05-31
ATE186295T1 (de) 1999-11-15
BR9711954A (pt) 1999-08-24
JP3090960B2 (ja) 2000-09-25
US6172111B1 (en) 2001-01-09
CN1076343C (zh) 2001-12-19
AU727524B2 (en) 2000-12-14
JPH11509560A (ja) 1999-08-24
ES2139465T3 (es) 2000-02-01
DK0894083T3 (da) 2000-04-03
GR3031754T3 (en) 2000-02-29
NO311354B1 (no) 2001-11-19
SK155698A3 (en) 1999-05-07
AU5857698A (en) 1998-07-17
EP0894083A1 (de) 1999-02-03
TR199900470T2 (xx) 1999-06-21
PL330279A1 (en) 1999-05-10
CZ362698A3 (cs) 1999-03-17
WO1998028263A1 (de) 1998-07-02
RU2179970C2 (ru) 2002-02-27
SK283195B6 (sk) 2003-03-04
IL127148A (en) 2002-11-10
NZ332830A (en) 2000-04-28
BG102932A (en) 1999-09-30
IL127148A0 (en) 1999-09-22

Similar Documents

Publication Publication Date Title
BG63537B1 (bg) Креатинови пирувати и метод за тяхното получаване
US6166249A (en) Creatine pyruvates
US5863939A (en) Creatine ascorbates and a method of producing them
JPWO2006001345A1 (ja) L−リジン・クエン酸塩結晶
US20050037069A1 (en) Solid and stable creatine/citric acid composition(s) and compositions carbohydrate(s) or hydrates thereof, method for the production and use thereof
US6203827B1 (en) Composition containing readily absorbable calcium and process for producing the same
JP2006265202A (ja) α−リポ酸アミノ酸塩
EP0420224B1 (en) Antihepatopathic composition
JPS5865214A (ja) N−アシル−l−アスパルチルタウリンを含有する医薬
MXPA98010488A (en) Creatine pyruvates and method for their production
RU1838296C (ru) Производные арилсульфокислот, проявляющие гипогликемическую активность
US6342631B1 (en) Method of producing calcium pyruvates
EP0923932B1 (en) Composition containing antitumor agent
KR20000016221A (ko) 크레아틴 피루베이트 및 이의 제조 방법
CA2296017A1 (en) Method for producing calcium pyruvates
PL104763B1 (pl) Sposob wytwarzania nowej postaci krystalicznej soli sodowej kwasu 7-cyjanoacetyloamino-3-acetoksymetylocefem-3-karboksylowego-4
GB2344996A (en) A solid stable aggregate formed from a pyruvate component and a carbohydrate component
CA1290761C (en) Chemical complex of potassium acetylsalicylate and preparation thereof
US7511173B2 (en) Creatine salt with enhanced nutritional and therapeutic efficacy and compositions containing same
KR100461572B1 (ko) L-카르니틴 칼슘 염과 이의 제조방법
US2478984A (en) Medicinal preparation containing available calcium and phosphorus
KR900000747B1 (ko) 비경구용 세파만돌 나페이트 제제의 제조방법
CA2247329C (en) Composition containing antitumor agent
MXPA99011864A (en) Method for producing calcium pyruvates
FR2597341A1 (fr) Solution pharmaceutique contenant de chelates de l-3,4-dihydroxyphenyl-alpha-methylalanine et procede pour la preparation de celle-ci.